State University of Medicine and Pharmacy, Moldova Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2016
NCT02565719
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

Infectious Diseases Department, State University of Medicine and Pharmacy, Infectious Clinical Hospital (n.a. Toma Clorba), Chisinau, Moldova, Republic of 2004

Active Ingredients

Drugs in Phase 2 Trials (4)

interferon alpha-2b (Intron-A) (1 trial)

rep 2139 (1 trial)

rep 2165 (1 trial)

tenofovir (viread) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hepatitis (Phase 2)

Hepatitis A (Phase 2)

Hepatitis B (Phase 2)

Hepatitis B, Chronic (Phase 2)

Hepatitis, Chronic (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 4